Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06849206 · ClinicalTrials.gov registry record

Pennington Generation Cohort

A clinical trial of Obesity Prevention, sponsored by Pennington Biomedical Research Center.

Recruiting
Registry status
3,000
Enrollment target
1
Study location

NCT06849206: Recruiting study of Obesity Prevention, sponsored by Pennington Biomedical Research Center.

NCT06849206 is a study of Obesity Prevention that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 3,000 participants, above the 1,277-participant average among 13 other Obesity Prevention trials with a reported enrollment target (135% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06849206, a study of Obesity Prevention, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.

RECRUITING
Registry status
3,000 participants
Enrollment target
1
Study location

Study Summary

The Pennington Generation Cohort is an observational study comprised of Louisiana families. Families will be assessed at baseline for a variety of traits and behaviors, and then followed up over time to try to understand the role of lifestyle and the environment on the risk of developing obesity and other health outcomes.

Primary Outcome

The development of obesity, defined using BMI z-scores during childhood, and BMI during adulthood.

Conditions Studied

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2025-02-24
Est. Completion 2045-02-24

What NCT06849206 shows while recruiting

NCT06849206 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,277-participant average among 13 other Obesity Prevention trials with a reported enrollment target (135% higher).

The record links to 1 condition, with Obesity Prevention appearing as the primary indexed condition, and to 0 interventions.

NCT06849206 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT06849206 about?

NCT06849206 is a clinical study titled "Pennington Generation Cohort". The Pennington Generation Cohort is an observational study comprised of Louisiana families. Families will be assessed at baseline for a variety of traits and behaviors, and then followed up over time to try to understand the role of lifestyle and the environment on the risk of developing obesity and...

What is the current status of trial NCT06849206?

This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2025-02-24. Estimated completion is 2045-02-24.

What conditions does trial NCT06849206 study?

This clinical trial studies the following conditions: Obesity Prevention.

Who is sponsoring clinical trial NCT06849206?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06849206 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06849206's enrollment target sits among peer trials

3,000 3rd of 13 higher than 11 of 13 other Obesity Prevention trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06849206, the US trial registry maintained by the National Library of Medicine. NCT06849206 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.